期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY LetPub Score 6.8
51 ratings
Rate
Reputation 7.6 Influence 5.6 Speed 8.9 | ||||||||||||||||
期刊簡稱 | J DRUG DELIV SCI TEC | ||||||||||||||||
ISSN | 1773-2247 | ||||||||||||||||
E-ISSN | 2588-8943 | ||||||||||||||||
h-index | 38 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 8.90%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | http://www.journals.elsevier.com/journal-of-drug-delivery-science-and-technology/ | ||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/JDDST | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Editions de Sante | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | FRANCE | ||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||
創刊年 | 2004 | ||||||||||||||||
每年文章數 | 1018每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 7.21% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1773-2247%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Slow, 6-12 Week(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY] 的評論 | 撰寫評論 |
作者: Hexinx 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-22 08:32:25 評論於 May I ask if you have heard any news after submitting your manuscript? I have also submitted one month ago with the editor.(0) 讚! | Hexinx |
作者: wgc0321 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-19 00:25:12 評論於 It has been one month since working with the editor(0) 讚! | wgc0321 |
作者: JYLiang 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-15 09:38:12 評論於 4.6投出,现在仍是正在处理(0) 讚! | JYLiang |
作者: Hyman Katte 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-25 18:19:18 評論於 Review Speed: 6.0 | Submission Hit Rate: 50.0 Emphasized Research Direction: Drug Administration Review Experience Sharing: About 1 week after submission in February 23 years ago, the first review comments were returned in June. Reviewer 1 had 4 minor revisions, Reviewer 2 had 16 major revisions and 5 minor revisions. The revised manuscript was submitted in August, with Reviewer 1's approval and no feedback from Reviewer 2. The overall quality of the manuscript is high, but the review process was slow. Waiting for 4 months was too long, but the outcome was good(0) 讚! | Hyman Katte |
作者: manbuzhe 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-11 12:34:01 評論於 The efficiency of handling articles in this magazine is very low, and the underview time is very long(1) 讚! | manbuzhe |
作者: 城门楼子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-05 11:12:06 評論於 I changed the magazine directly because it was rejected for having a repetition rate of over 30%.(0) 讚! | 城门楼子 |
作者: 城门楼子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-01 17:41:53 評論於 Directly transferred over with one click, submitted to the system on April 18th, and was already in the hands of the editor on the same day. When checked on April 28th, it still hadn't been reviewed, but noticed that the "with editor" status update time had changed from April 18th to April 23rd. It's the first time encountering a situation where the last update time of the manuscript status was modified, very strange...(0) 讚! | 城门楼子 |
作者: 一条小平良 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-28 13:47:26 評論於 Review speed: 3.0 | Submission success rate: 50.0 Highlighted research direction: controlled release; Drug experience sharing: Submit by June 1, 2022, under review by July 1, 2022. Received reviewer comments on September 1, 2022: Two reviewers, each with 10 comments, not very difficult to respond to, but additional experiments are required. Revised on October 25, 2022, and reviewer requested additional experiments again on November 6, 2022. Revised again after resubmission on November 26, 2022, and accepted on December 28, 2022. Overall, it is quite slow. Please consider carefully(0) 讚! | 一条小平良 |
作者: 西行寺莉莉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-13 12:10:44 評論於 Under review(0) 讚! | 西行寺莉莉 |
作者: 晨风永生 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-22 17:12:29 評論於 Hello, may I ask when the layout fee is generally notified for payment?(0) 讚! | 晨风永生 |
作者: 仲夏灵蕊 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-21 12:07:22 評論於 Can you recommend any English journals without page charges?(0) 讚! | 仲夏灵蕊 |
作者: 寻山酱大魔王 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-24 15:22:44 評論於 Review speed: 6.0 Experience sharing: The review speed is too slow, wasting too much time. After 5 months of review, the paper was rejected. It's really disappointing(0) 讚! | 寻山酱大魔王 |
作者: 1122~~~~ 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-01 15:19:47 評論於 It has been three months since submission, and still no news... Is this magazine's review process very slow?(0) 讚! | 1122~~~~ |
作者: 晨风永生 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-25 20:34:23 評論於 Does the magazine need protein original data?(0) 讚! | 晨风永生 |
作者: 晨风永生 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-25 19:35:19 評論於 Is this magazine strict about WB raw data requirements?(0) 讚! | 晨风永生 |
作者: 晨风永生 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-25 18:02:54 評論於 Hello, may I ask if this magazine has strict requirements for WB raw data?(0) 讚! | 晨风永生 |
作者: 晨风永生 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-25 11:36:45 評論於 Hello, I would like to ask if the magazine has high requirements for WB raw data(0) 讚! | 晨风永生 |
作者: 仙灵兰芹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-20 22:14:12 評論於 Excuse me, how can I invest? Can I just register directly? Are there any other materials needed?(0) 讚! | 仙灵兰芹 |
作者: 仙灵兰芹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-20 16:37:27 評論於 Is this magazine relatively easy compared to some others, how many months have you been accepted?(0) 讚! | 仙灵兰芹 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 09:31:26 評論於 The keywords of a SCI paper are generally 3 to 8(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 09:02:37 評論於 Please translate the following paragraph into English and Japanese, and label them as ":" and ":"(0) 讚! | 维尔娜菲茨杰拉德 |
作者: xujun 領域: 化学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2021-12-27 19:51:50 評論於 One round of peer review took 35 days, and all four reviewers accepted the revised manuscript. A total of 21 issues were identified, and the editor requested major revisions, including the addition of some cell experiments. The revised manuscript was submitted one month later for a second round of peer review, which lasted three weeks. Because the reviewers' comments were all addressed as requested, the manuscript was accepted without further revisions. However, the editor found some language issues and recommended the use of a proofreading service. The manuscript was returned one week later. The submission was made on September 1, 2021, and the acceptance was received on December 20, 2021. The publication was released on December 24. The entire process lasted for three months and 20 days.(0) 讚! | xujun |
作者: 平原文波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 15:33:00 評論於 How many keywords do general journals require?(0) 讚! | 平原文波 |
作者: Darlene Pepys 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 13:49:15 評論於 How few keywords are essential for?(0) 讚! | Darlene Pepys |
作者: 水桥珍珍 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-06 13:05:34 評論於 Is this magazine in the "under review" stage? My submission has been in the "with editor" stage since I submitted it(0) 讚! | 水桥珍珍 |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us